Earnings Preview: Corcept Therapeutics

Corcept Therapeutics (NASDAQ:CORT) is gearing up to announce its quarterly earnings on Wednesday, 2024-10-30. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Corcept Therapeutics will report an earnings per share (EPS) of $0.28.

Corcept Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

During the last quarter, the company reported an EPS beat by $0.09, leading to a 1.12% drop in the share price on the subsequent day.

Here's a look at Corcept Therapeutics's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

0.23

0.22

0.26

0.21

EPS Actual

0.32

0.25

0.28

0.28

Price Change %

-1.0%

5.0%

-7.000000000000001%

-10.0%

Stock Performance

Shares of Corcept Therapeutics were trading at $48.34 as of October 28. Over the last 52-week period, shares are up 70.24%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analyst Insights on Corcept Therapeutics

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest ...